Synageva BioPharma

About:

Synageva, a biopharmaceutical company, develops and commercializes novel, next generation and follow on protein therapeutics.

Website: http://www.synageva.com

Top Investors: New Leaf Venture Partners, Baker Brothers Advisors LLC, Tullis Health Investors, Kitty Hawk Capital, Cordova Ventures

Description:

Synageva is a biopharmaceutical company dedicated to developing and commercializing novel, next generation and follow on protein therapeutics that leverage the unique competitive advantages of their proprietary Synageva Expression Platform (SEPTM).

Total Funding Amount:

$597M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

1996-01-01

Contact Email:

info(AT)synageva.com

Founders:

Sanj K. Patel

Number of Employees:

251-500

Last Funding Date:

2015-01-05

IPO Status:

Delisted

© 2025 bioDAO.ai